Medicinal cannabis company Bod Australia is working with the University of Technology Sydney (UTS) to investigate whether CBD boosts the anti-toxification process in cells.
A previous three-year study found that humans have protein cells which can act as a carrier for CBD into the body. These cells also have anti-toxicant properties; this latest study aims to test whether the addition of CBD could boost this effect.
Adele Hosseini, chief business officer at Bod Australia, hopes the research could have implications for both the commercial sector and therapeutically.
In an interview with Business Insider Australia, she also criticised current regulations in the Australian cannabis industry: “We especially think that the rules need to be relaxed a lot more around the non-psychoactive cannabinoids because they have definitely proved to have fewer side effects.”
UTS professor Dr Stella Valenzuela also recognised the future potential benefits of CBD skincare products.
“They offer a number of new opportunities for translation of our research into products for use in the beauty and healthcare,” she said.
Get your 100% free subscription to Cannabis Health magazine
Cannabis Health is THE UK magazine covering cannabis medicine and wellbeing from every angle. It is affiliated with the Medical Cannabis Clinicians Society and lists campaigner Hannah Deacon, leading expert Professor Mike Barnes and prominent doctor Dani Gordon on our editorial panel. For a limited time only, we are offering a free – absolutely no strings – annual subscription to the quarterly print title. You will receive four issues, delivered with discretion to your address – with no hidden fees or obligation to pay beyond that. To repeat, this is a 100% free promotion available to the first 100,000 sign-ups.